Losartan and end-organ protection--lessons from the RENAAL study.

@article{Kowey2005LosartanAE,
  title={Losartan and end-organ protection--lessons from the RENAAL study.},
  author={Peter Russell Kowey and Tania Z Dickson and Zhongxin Zhang and Shahnaz Shahinfar and Barry M. Brenner},
  journal={Clinical cardiology},
  year={2005},
  volume={28 3},
  pages={136-42}
}
BACKGROUND The Reduction in ENdpoints with the Angiotensin Antagonist Losartan (RENAAL) study reported that losartan delayed the progression of renal disease in patients with type 2 diabetes and nephropathy. Diabetic or renally impaired patients are at high cardiovascular risk, a risk potentially increased in patients with both conditions. HYPOTHESIS This post hoc analysis examined whether baseline proteinuria was predictive of cardiovascular outcomes, and whether losartan modifies the risk… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Neprilysin inhibition in chronic kidney disease

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2015

Association between proteinuria and left ventricular mass index: a cardiac MRI study in patients with chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2011

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2011

Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2009
View 1 Excerpt

Similar Papers

Loading similar papers…